LENSAR, (id:5950 LNSR)

7.45 USD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 7:12:25 PM)

Exchange closed, opens in 14 hours 17 minutes

• 1 day
• 1 week
• 1 month
• 6 months
• 1 year
• All

About LENSAR,

Market Capitalization 85.79M

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.